Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report

@article{Crippa2013CannabidiolFT,
  title={Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report},
  author={J. Crippa and J. Hallak and J. P. Machado-de-Sousa and R. Queiroz and M. Bergamaschi and M. H. Chagas and A. W. Zuardi},
  journal={Journal of Clinical Pharmacy and Therapeutics},
  year={2013},
  volume={38}
}
  • J. Crippa, J. Hallak, +4 authors A. W. Zuardi
  • Published 2013
  • Medicine
  • Journal of Clinical Pharmacy and Therapeutics
  • What is known and Objective: Cannabis withdrawal in heavy users is commonly followed by increased anxiety, insomnia, loss of appetite, migraine, irritability, restlessness and other physical and psychological signs. Tolerance to cannabis and cannabis withdrawal symptoms are believed to be the result of the desensitization of CB1 receptors by THC. 
    57 Citations
    Marijuana: Current Concepts†
    • 74
    • PDF
    The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review
    • 11
    • Highly Influenced
    • PDF
    Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
    • 18
    Is there a role for cannabidiol in psychiatry?
    • Julia Machado Khoury, M. G. Neves, +5 authors F. García
    • Psychology, Medicine
    • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
    • 2019
    • 14

    References

    SHOWING 1-10 OF 38 REFERENCES
    Cannabis and anxiety: a critical review of the evidence
    • 314
    The cannabis withdrawal syndrome
    • 274
    • Highly Influential
    • PDF
    Marijuana Dependence and Its Treatment
    • 195
    • PDF
    Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor
    • 70
    Review of the validity and significance of cannabis withdrawal syndrome.
    • 403
    • PDF
    Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex
    • 229
    • PDF
    The endocannabinoid system as a target for the treatment of cannabis dependence
    • 80
    • PDF
    Challenges in Using Opioids to Treat Pain in Persons With Substance Use Disorders
    • 216
    • PDF
    Safety and side effects of cannabidiol, a Cannabis sativa constituent.
    • 267
    • PDF
    Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
    • 567
    • PDF